6/18/2013

Researchers at Astellas Pharma and Kyoto University have developed a method to produce nephron progenitor cells from human induced pluripotent stem cells and human embryonic stem cells using various growth factors and chemical compounds. Scientists reported at a stem cell research meeting that the differentiated nephron progenitor cells demonstrated the qualities of natural nephron progenitor cells. This points to the potential of the differentiation method in improving regenerative treatments for chronic renal failure and other refractory renal diseases, they say.

Related Summaries